Search
Profound Medical Corp
PROFAdd to Watchlist
6.100USD
+0.240+4.10%
Close 09-18 16:00（ET）
221.94MMarket Cap
LossP/E TTM
Profound Medical Corp (PROF) Stock Price Target & Forecast
Analyst Rating
Based on 5 analysts giving stock ratings to Profound Medical Corp in the past month.
Strong Buy
3 Strong Buy
2 Buy
0 Hold
0 Sell
0 Strong Sell
Target Price
11.050USD+87.61%
PROF Analyst Recommendation Trends
In the current month, PROF has received 2 Buy Ratings, 0 Hold Ratings, and 0 Sell Ratings. PROF average Analyst price target in the last month is 11.050.
2026-09
2026-08
2026-07
2026-06
2026-05
2026-04
2026-03
2026-02
3
3
2
2
2
2
2
2
2
2
3
3
3
3
3
3
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
5
5
5
5
5
5
5
5
PROF Analyst Rating for Peer Comparison
Updated: Sep 20, 2026Company name
Strong Buy
Buy
Hold
Sell
Strong Sell
Analysts
Boston Scientific Corp
BSX
11
17
6
0
0
34
Intuitive Surgical Inc
ISRG
11
13
9
1
0
34
Thermo Fisher Scientific Inc
TMO
10
16
6
0
0
32
Edwards Lifesciences Corp
EW
10
14
8
0
0
32
Veeva Systems Inc
VEEV
7
15
8
1
0
31
Danaher Corp
DHR
11
13
4
0
0
28
Waters Corp
WAT
8
10
9
0
0
27
Agilent Technologies Inc
A
6
11
7
0
0
24
Illumina Inc
ILMN
5
7
7
2
1
22
Resmed Inc
RMD
2
7
10
1
1
21
Financial Forecasting
Based on analysts' estimates, PROF EPS is projected to reach -0.227 in FY2026Q3, following reported EPS of -0.262 in FY2026Q2. Track earnings expectations against reported figures to see how profitability is evolving.
EPS
Revenue
Net Profit
EBIT
Forecast
Actual
FY2025Q4
FY2026Q1
FY2026Q2
FY2026Q3
FY2026Q4
Forecast
-0.28
-0.25
-0.24
-0.23
-0.18
Actual
-0.27
-0.19
-0.26
--
--
Surprise
+2.77%
+23.05%
-8.22%
--
--
FAQs
What is Profound Medical Corp's expected revenue for the next quarter?
Profound Medical Corp's expected revenue is 6.85M.
What is Profound Medical Corp's price target?
Analysts forecast that Profound Medical Corp's price target is USD 11.05, with the highest forecast at USD 12.00 and the lowest forecast at USD 10.00.
How have Profound Medical CorpPROF's recent earnings per share performed?
The market expectation was USD -0.26, while Profound Medical CorpPROF's earnings per share (EPS) for the previous quarter was USD -0.19. EPS for the next quarter is expected at USD -0.23.
What is the analyst rating for Profound Medical Corp?
Based on the ratings of Profound Medical Corp's stock from 5 analysts, most analysts support a STRONG BUY trend. After considering the opinions of other analysts, we ultimately rate Apple's stock as STRONG BUY. Please note that this is not trading advice. You still need to conduct your own analysis.